Company Filing History:
Years Active: 2024
Title: Kenneth Randall Chien: Innovator in RNA Therapeutics
Introduction
Kenneth Randall Chien is a prominent inventor based in Stockholm, Sweden. He has made significant contributions to the field of RNA therapeutics, particularly in the development of modified RNA molecules.
Latest Patents
Kenneth holds a patent for "Modified RNA encoding VEGF-A polypeptides, formulations, and uses relating thereto." This patent focuses on modified RNA molecules that encode VEGF-A polypeptides and formulations that include this modified RNA. The disclosure also covers preparations and applications of these formulations in treating conditions that respond to VEGF-A therapy. He has 1 patent to his name.
Career Highlights
Kenneth is associated with Modernatx, Inc., a company that specializes in innovative RNA-based therapies. His work has been pivotal in advancing the understanding and application of RNA technology in medical treatments.
Collaborations
He has collaborated with notable colleagues, including Leif Karlsson Parinder and Regina Desirée Fritsche Danielson, contributing to a dynamic research environment.
Conclusion
Kenneth Randall Chien's work in modified RNA therapeutics exemplifies the innovative spirit of modern science. His contributions are paving the way for new treatments that could significantly impact patient care.